| Model-informed COVID-19 vaccine prioritization strategies by age and serostatus KM Bubar, K Reinholt, SM Kissler, M Lipsitch, S Cobey, YH Grad, ... Science 371 (6352), 916-921, 2021 | 796 | 2021 |
| Estimating SARS-CoV-2 seroprevalence and epidemiological parameters with uncertainty from serological surveys DB Larremore, BK Fosdick, KM Bubar, S Zhang, SM Kissler, CJE Metcalf, ... Elife 10, e64206, 2021 | 86 | 2021 |
| Morning circadian misalignment is associated with insulin resistance in girls with obesity and polycystic ovarian syndrome SL Simon, L McWhirter, C Diniz Behn, KM Bubar, JL Kaar, L Pyle, ... The Journal of Clinical Endocrinology & Metabolism 104 (8), 3525-3534, 2019 | 73 | 2019 |
| Implications of test characteristics and population seroprevalence on ‘immune passport’strategies DB Larremore, KM Bubar, Y Grad | 21 | 2020 |
| SARS-CoV-2 transmission and impacts of unvaccinated-only screening in populations of mixed vaccination status KM Bubar, CE Middleton, KK Bjorkman, R Parker, DB Larremore Nature Communications 13 (1), 2777, 2022 | 8 | 2022 |
| Estimating SARS-CoV-2 seroprevalence and epidemiological parameters with uncertainty from serological surveys. medRxiv. 2020 DB Larremore, BK Fosdick, KM Bubar, S Zhang, SM Kissler, CJE Metcalf, ... Jun 22 (10.1101), 2020.04, 0 | 8 | |
| Advances in stable isotope tracer methodology part 1: hepatic metabolism via isotopomer analysis and postprandial lipolysis modeling C Diniz Behn, ES Jin, K Bubar, C Malloy, EJ Parks, M Cree-Green Journal of Investigative Medicine 68 (1), 3-10, 2020 | 6 | 2020 |
| Implications of Test Characteristics and Population Seroprevalence on “Immune Passport” DB Larremore, KM Bubar, YH Grad | 1 | 2020 |
| Transmission and Unvaccinated-Only Testing in Populations of Mixed Vaccination Status K Bubar, C Middleton, K Bjorkman, R Parker, D Larremore | | 2021 |
| 2019 Theoretical Division Lightning Talk Series ML Ramsey, QU Abfalterer, M Ahumada Paras, DA Armstrong, KM Bubar, ... Los Alamos National Lab.(LANL), Los Alamos, NM (United States), 2019 | | 2019 |
Daniel B. LarremoreBioFrontiers Inst. & CS Dept. - University of Colorado BoulderVerified email at colorado.edu
